Moderna Inc

NASDAQ:MRNA  
430.06
-10.59 (-2.40%)
5:12:40 PM EDT: $428.83 -1.23 (-0.29%)
Products

Moderna Says Completed Submission To U.S FDA For Evaluation Of A Booster Dose Of Co's COVID-19 Vaccine

Published: 09/03/2021 18:17 GMT
Moderna Inc (MRNA) - Moderna Says Completed Submission to US FDA , Which We Began on Wednesday, for Evaluation of a Booster Dose of the Moderna Covid-19 Vaccine - Tweet.
Further Company Coverage: Mrnao ((reuters.
Briefs@thomsonreuters.
Com;)).